Our Services

JDF Center for Gene Therapy Approaches to Type 1 Diabetes

The Juvenile Diabetes Foundation International (JDF) Center for Gene Therapy Approaches to Type 1 Diabetes at Children’s Hospital of Pittsburgh and the University of Pittsburgh marks a new approach to the treatment of Type 1 diabetes, using gene therapy to improve islet cell transplantation for insulin replacement therapy and to treat neurologic complications.

The goal of the center is to advance the practice of islet transplantation en route to developing a cure for diabetes. For the first time, the new center brings together world-renowned experts in the fields of immunogenetics, transplantation and gene therapy to work toward the common goal of curing Type 1 diabetes.

Massimo Trucco, MD, chief, division of immunogenetics at Children’s Hospital of Pittsburgh, is the director of the center. Thomas E. Starzl, MD, PhD, professor of surgery at the University of Pittsburgh School of Medicine, and Joseph Glorioso, PhD, professor and chairman of the department of molecular genetics and biochemistry at the University of Pittsburgh School of Medicine, are the co-directors.

Several projects and core facilities are funded through the Center.

Last Update
March 29, 2010

top